1. A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer (Study 006). Issue 2 (7th September 2022) Authors: Tanyi, Janos L.; Randall, Leslie M.; Chambers, Setsuko K.; Butler, Kristina A.; Winer, Ira S.; Langstraat, Carrie L.; Han, Ernest S.; Vahrmeijer, Alexander L.; Chon, Hye Sook; Morgan, Mark A.; Powell, Matthew A.; Tseng, Jill H.; Lopez, Alexis S.; Wenham, Robert M. Journal: Journal of clinical oncology Issue: Volume 41:Issue 2(2023) Page Start: 276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Management of squamous cell vulvar cancer: A review. Issue 5 (21st April 2014) Authors: Deppe, Gunter; Mert, Ismail; Winer, Ira S. Journal: Journal of obstetrics and gynaecology research Issue: Volume 40:Issue 5(2014:May) Page Start: 1217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ONC201 induces the unfolded protein response (UPR) in high‐ and low‐grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity. (1st May 2021) Authors: Rumman, Marufa; Buck, Steven; Polin, Lisa; Dzinic, Sijana; Boerner, Julie; Winer, Ira S. Journal: Cancer medicine Issue: Volume 10:Number 10(2021) Page Start: 3373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗